University of Pittsburgh: Communicable Diseases trials

The registry lists 13 Communicable Diseases studies with University of Pittsburgh as lead sponsor. 0 are open to participants now and 2 have results posted.

Phase 4 2No phase 11(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Immunoglobulin Levels and Occurrence of Infections After Lung Transplantation and Impact of IgG ReplacementCompletedNCT01361178Not applicableResults posted
• Anidulafungin Versus Fluconazole for the Prevention of Fungal Infections in Liver Transplant RecipientsCompletedNCT00841971Phase 4Results posted
• Evaluation of Fidaxomicin in the Treatment of Clostridium Difficile Infection (CDI)WithdrawnNCT04070352
• Pharmacokinetic Analysis of Posaconazole in Lung Transplant RecipientsCompletedNCT01419678Not applicable
• Multinational Study of Acinetobacter Bloodstream Infection: Clinical Outcomes and Global Epidemiology-PITT ProtocolCompletedNCT00524290
• Ventricular Shunt and Drain Infections - Timing of ReimplantationCompletedNCT00470132
• Changing Patterns of Candida Infections in Urban Medical CentersCompletedNCT00366223
• Community - Associated Extended-spectrum Beta-lactamases (ESBL)CompletedNCT00363220
• Infectious Outcomes Following Pancreas TransplantationCompletedNCT00332111
• A Retrospective Review of Infections Usually Observed in Transplant RecipientsCompletedNCT00298077
• Invasive Fungal Infections Surveillance InitiativeCompletedNCT00177944
• Organ Transplant Infection Prevention and Detection ProjectCompletedNCT00177801
• Limited Access Protocol of Posaconazole in Invasive Fungal Infections Study PO2095TerminatedNCT00177749Phase 4